Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789

Clinical trial NCT00795730 · COMPLETED

Trial details

NCT number: NCT00795730
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Healthy Subjects

Start date: 2009-01-01
Primary completion: 2009-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.